ADIAL PHARMACEUTICALS, INC.
Nasdaq · CIK 0001513525 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-07-16 | 0001104659-26-084300 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-07-13 | 0001104659-26-082972 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-07-01 | 0001104659-26-079686 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-06-16 | 0001213900-26-069037 |
| 10-Q | ADIAL PHARMACEUTICALS, INC. | 2026-05-08 | 0001213900-26-053907 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-04-09 | 0001213900-26-042054 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-04-09 | 0001213900-26-042052 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-04-09 | 0001213900-26-042053 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-04-09 | 0001213900-26-042051 |
| 4 | ADIAL PHARMACEUTICALS, INC. | 2026-04-09 | 0001213900-26-042050 |
| 10-K | ADIAL PHARMACEUTICALS, INC. | 2026-03-05 | 0001213900-26-024175 |
| 10-Q | ADIAL PHARMACEUTICALS, INC. | 2025-11-13 | 0001213900-25-109979 |
| 10-Q | ADIAL PHARMACEUTICALS, INC. | 2025-08-13 | 0001213900-25-075695 |